Form 4: Ideaya Biosciences Executive Acquires 185,000 Stock Options
SEC Form 4 Filing
Michael Anthony White, Chief Scientific Officer of Ideaya Biosciences, acquired 185,000 stock options on February 27, 2025, at an exercise price of $20.24.
Summary
- On February 27, 2025, Michael Anthony White, the Chief Scientific Officer of Ideaya Biosciences, Inc., acquired 185,000 stock options.
- The exercise price for these options is $20.24 per share.
- The options vest over a four-year period, starting January 1, 2025, with 25% vesting on the first anniversary and the remainder vesting monthly thereafter.
- The expiration date for these options is February 26, 2035.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing. It simply reports a transaction and doesn't convey any positive or negative sentiment about the company's performance or prospects.
Industry Context
This is a standard SEC Form 4 filing, reflecting a change in beneficial ownership of securities by a company insider. It is common for executives to receive stock options as part of their compensation packages, aligning their interests with those of the shareholders.
Stakeholder Impact
- The acquisition of stock options by a key executive aligns their interests with shareholders, potentially incentivizing them to improve company performance.
Key Dates
| Date | Description |
|---|---|
| January 1, 2025 | Vesting Commencement Date for the stock options |
| February 27, 2025 | Date of transaction: Michael Anthony White acquired 185,000 stock options |
| February 28, 2025 | Date of signature for the Form 4 filing |
| February 26, 2035 | Expiration date of the stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.